Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AzaSite in blepharitis
NCT00629980Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2008
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of AzaSite in blepharitis, sponsored by Merck & Co. Primary endpoint: Change in clinical signs and symptoms associated with blepharitis at 4 weeks. Started Feb 2008; status: completed.
02
Drugs
AzaSite
03
Conditions
blepharitis
Beyond the preview
Go deeper on NCT00629980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00629980.